Julie Gralow - Dissemin

All papers authored by Julie Gralow

This paper is made freely available by the publisher.

Delaney V. Rutherford

, Sarah Medley

, Nicholas C. Henderson

, Christina L. Gersch

, Ted A. Vandenberg

, Kathy S. Albain

, Shaker R. Dakhil

, Nagendra R. Tirumali, Julie R. Gralow

, Gabriel N. Hortobagyi

, Lajos Pusztai

, Rita S. Mehta, Daniel F. Hayes

, Kelley M. Kidwell

, N. Lynn Henry

and 3 other authors

Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae

Figure S2 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow

, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James B. Hicks, Lisa Welter, Philip A. Dy, Christina H. Yeon, Alison K. Conlin, Ernie Balcueva, Danika L. Lew, Debasish Tripathy and 2 other authors

Supplementary Figure from A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222

Upload

Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow

, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James B. Hicks, Lisa Welter, Philip A. Dy, Christina H. Yeon, Alison K. Conlin, Ernie Balcueva, Danika L. Lew, Debasish Tripathy and 2 other authors

Data from A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222

Upload

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae

Table S2 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae

Figure S1 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae

Table S1 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

2022 Kathryn F. Mileham

, Suanna S. Bruinooge

, Charu Aggarwal

, Alicia L. Patrick, Christiana Davis, Daniel J. Mesenhowski, Alexander Spira

, Eric J. Clayton

, David Waterhouse

, Susan Moore, Abdul-Rahman Jazieh

, Ronald C. Chen, Melinda Kaltenbaugh

, Jen Hanley Williams, Julie R. Gralow

and 2 other authors

Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry

Download from doi.org

2021 Ian E. Krop

, Seock-Ah Im

, Carlos Barrios

, Hervé Bonnefoi

, Julie Gralow

, Masakazu Toi

, Paul A. Ellis, Luca Gianni

, Sandra M. Swain

, Young-Hyuck Im, Michelino De Laurentiis

, Zbigniew Nowecki

, Chiun-Sheng Huang

, Louis Fehrenbacher

, Yoshinori Ito and 8 other authors

Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: The Phase III KAITLIN Study

Download from doi.org

Beverly Moy, R. Bryan Rumble, Steven E. Come

, Nancy E. Davidson, Angelo Di Leo

, Julie R. Gralow

, Gabriel N. Hortobagyi

, Douglas Yee

, Ian E. Smith, Mariana Chavez-Macgregor

, Rita Nanda

, Heather L. McArthur

, Laura Spring

, Katherine E. Reeder-Hayes

, Kathryn J. Ruddy

and 9 other authors

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update

Download from doi.org

Nicoleta Antone

, Darya Kizub

, Julie Gralow

, Jo Anne Zujewski

, Allison Dvaladze

Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women’s Empowerment Cancer Advocacy Network (WE CAN) Summits

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Halle C. F. Moore

, William E. Barlow, George Somlo, Julie R. Gralow

, Anne F. Schott, Daniel F. Hayes

, Peter Kuhn

, James B. Hicks

, Lisa Welter

, Philip A. Dy, Christina H. Yeon, Alison K. Conlin, Ernie Balcueva, Danika L. Lew, Debasish Tripathy

and 2 other authors

A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor–positive Breast Cancer, SWOG S1222

Upload

Costanza Paoletti

, William E. Barlow, Erin F. Cobain

, Mattias Bergqvist

, Rita S. Mehta, Julie R. Gralow

, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai

, Priyanka Sharma, Andrew K. Godwin

, Alastair M. Thompson, Daniel F. Hayes

, James M. Rae

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Upload

Dawn L. Hershman

, Alfred I. Neugut, Anna Moseley

, Kathryn B. Arnold, Julie R. Gralow

, N. Lynn Henry

, Grace Clarke Hillyer

, Scott D. Ramsey, Joseph M. Unger

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

Upload

Rachel L. Yung

, Julie R. Gralow

Time to Focus on Breast Cancer in Young Adults

Download from doi.org

Lynn Symonds

, Poorna Natarajan, Richard K. Cheng, Diana L. Lam, Mark Kilgore, Janice Kim, Kristine Calhoun, Elina Minami, Julie R. Gralow

When cardiomyopathy, cancer, and COVID‐19 collide: A case report

Download from onlinelibrary.wiley.com

Dario Trapani

, Jean Yves Douillard, Jean Yves Douillard

, Eric P. Winer

, Harold Burstein, Lisa Anne Carey, Lisa Anne Carey

, Javier Cortes, Gilberto Lopes, Julie R. Gralow

, William J. Gradishar, Nicola Magrini, Giuseppe Curigliano

, Andrè M. Ilbawi

The global landscape of treatment standards for breast cancer

Download from academic.oup.com

2020 Julie R. Gralow

, Fredrick Chite Asirwa, Ami Siddharth Bhatt

, Maria T. Bourlon

, Quyen Chu

, Alexandru E. Eniu, Patrick J. Loehrer

, Gilberto Lopes, Lawrence N. Shulman

, Julia Close, Jamie Von Roenn, Michal Tibbits, Doug Pyle

Recommendations from the ASCO Academic Global Oncology Task Force

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Julie Gralow